Promising prostate cancer drug candidates identified
Cancer researchers have identified some promising drug candidates by using high-throughput screening methods to test tens of thousands of molecules.
Read moreCancer researchers have identified some promising drug candidates by using high-throughput screening methods to test tens of thousands of molecules.
Read morePTEN, a tumor suppressor gene mutated in about 20% of prostate cancers, relies on another gene, ARID4B, to function.
Read moreSelective mammography screening can provide potentially lifesaving early detection of breast cancer in men who are at high risk for the disease, according to a new landmark study.
Read moreFemale athletes seek specialty medical treatment later than male athletes for sports-related concussions (SRC), and this delay may cause them to experience more symptoms and longer recoveries.
Read moreA drug used to treat enlarged prostate may also slow the progression of Parkinson's disease, according to a new study.
Read moreDespite its proven success at preventing cancer, many adolescents are still not getting the HPV vaccine. A new study from shows that physicians' delivery and communication practices must improve to boost vaccination completion rates.
Read more